Equinoxe
Device Orthopaedic
PDI 10885862086419
General payments
$15,653,224
Research payments
$6,012,185
Through program year 2025, $15,653,224 in general payments and $6,012,185 in research payments were reported against Equinoxe (Orthopaedic).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $1,525,076 | 97 |
| 2024 | General | $5,131,565 | 1,157 |
| 2024 | Research | $1,585,740 | 92 |
| 2023 | General | $4,874,544 | 1,607 |
| 2023 | Research | $1,589,073 | 80 |
| 2022 | General | $5,240,525 | 1,705 |
| 2022 | Research | $1,312,295 | 83 |
| 2021 | General | $406,591 | 5 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.
The top 5 of 18 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 39 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
4,474 general · 352 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.